Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow’s Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

PrabotulinumtoxinA has been identified as an effective agent against crow’s feet. Our study, which included Korean patients with moderate to severe crow’s feet, was undertaken to compare the efficacy and safety of PrabotulinumtoxinA and placebo treatments. Of the 90 study participants, 60 received p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soo-Kyung, Kim, Myoung Shin, Kwon, Soon-Hyo, Chung, Bo Young, Han, Se Hee, Kim, Hyoung Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573474/
https://www.ncbi.nlm.nih.gov/pubmed/37834970
http://dx.doi.org/10.3390/jcm12196326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573474/
https://www.ncbi.nlm.nih.gov/pubmed/37834970
http://dx.doi.org/10.3390/jcm12196326

Ejemplares similares